KMK Stock Overview
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear, CBRNe security, and safety screening markets.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Kromek Group plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.058 |
52 Week High | UK£0.087 |
52 Week Low | UK£0.03 |
Beta | 1.04 |
1 Month Change | -19.58% |
3 Month Change | 19.79% |
1 Year Change | -10.16% |
3 Year Change | -64.17% |
5 Year Change | -77.23% |
Change since IPO | -90.38% |
Recent News & Updates
Recent updates
Kromek Group plc (LON:KMK) Soars 46% But It's A Story Of Risk Vs Reward
Feb 13Kromek Group plc's (LON:KMK) Price In Tune With Revenues
Dec 28Kromek Group plc's (LON:KMK) Revenues Are Not Doing Enough For Some Investors
Apr 19Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt
Aug 04Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely
Sep 02Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares
Jan 14Shareholder Returns
KMK | GB Semiconductor | GB Market | |
---|---|---|---|
7D | 10.6% | 2.7% | 2.3% |
1Y | -10.2% | 24.5% | 2.7% |
Return vs Industry: KMK underperformed the UK Semiconductor industry which returned 24.5% over the past year.
Return vs Market: KMK underperformed the UK Market which returned 2.7% over the past year.
Price Volatility
KMK volatility | |
---|---|
KMK Average Weekly Movement | 9.1% |
Semiconductor Industry Average Movement | 8.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: KMK's share price has been volatile over the past 3 months.
Volatility Over Time: KMK's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 166 | Arnab Basu | https://www.kromek.com |
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and devices for the medical imaging, civil nuclear, CBRNe security, and safety screening markets. The company’s products provide high resolution information on material composition and structure that are used in various applications. It also offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray, x-ray, and neutron detection.
Kromek Group plc Fundamentals Summary
KMK fundamental statistics | |
---|---|
Market cap | UK£35.87m |
Earnings (TTM) | -UK£4.10m |
Revenue (TTM) | UK£17.62m |
2.0x
P/S Ratio-8.8x
P/E RatioIs KMK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KMK income statement (TTM) | |
---|---|
Revenue | UK£17.62m |
Cost of Revenue | UK£7.57m |
Gross Profit | UK£10.05m |
Other Expenses | UK£14.14m |
Earnings | -UK£4.10m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0066 |
Gross Margin | 57.01% |
Net Profit Margin | -23.25% |
Debt/Equity Ratio | 18.8% |
How did KMK perform over the long term?
See historical performance and comparison